Not available
Quote | Melinta Therapeutics Inc - Ordinary Shares (NASDAQ:MLNT)
Last: | $ |
---|---|
Change Percent: | -12.00% |
Open: | $0.44 |
Close: | $0.44 |
High: | $0.46 |
Low: | $0.31 |
Volume: | 1,107,248 |
Last Trade Date Time: | 01/13/2020 04:33:26 pm |
News | Melinta Therapeutics Inc - Ordinary Shares (NASDAQ:MLNT)
MORRISTOWN, N.J., June 24, 2020 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (“Melinta”), a commercial-stage antibiotics company, announced that on June 24, 2020, pursuant to the Agreement and Plan of Merger by and among Melinta, Toronto Transaction Corp. (“Purch...
The bidding competition for Tetraphase Pharmaceuticals (NASDAQ: TTPH ) is not over yet. La Jolla Pharmaceutical (NASDAQ: LJPC ) has submitted an unsolicited bid of $43.0M in cash plus an additional $16.0 payable under contingent value rights (CVRs). More news on: Tetraphase Pharmaceutica...
Message Board Posts | Melinta Therapeutics Inc - Ordinary Shares (NASDAQ:MLNT)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Melinta Therapeutics Inc - Ordinary Shares Company Name:
MLNT Stock Symbol:
NASDAQ Market:
MORRISTOWN, N.J., June 24, 2020 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (“Melinta”), a commercial-stage antibiotics company, announced that on June 24, 2020, pursuant to the Agreement and Plan of Merger by and among Melinta, Toronto Transaction Corp. (“Purch...
Company Enters Growth Phase in Hospital Market with Support of Deerfield Acquisition to Augment Company’s Core Antibiotic Portfolio MORRISTOWN, N. J. , June 09, 2020 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (“Melinta”), a commercial-stage antibiotic...
Bids due on March 2, 2020 by 4:00 p.m. Eastern Time Company Previously Announced Agreement of its Secured Lenders to Acquire Company as Going Concern, Subject to Higher and Better Offers Company Continues Operations with No Anticipated Disruption to Product Supply or Support MO...